Today's Hospitalist

JUNE 7, 2025

THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. Published in May 2024, the FLOW trial , for instance, looked at patients with diabetes and advanced kidney disease.

Hospital 66

Hospital Management Diabetes Patients 66

GeriPal

JANUARY 18, 2024

ABIM MOC credit will be offered to subscribers in November, 2024. Why would CBT work for neuropathic pain and diabetes differently than it would work for neuropathic pain and cancer? Eric: This comes down to also like, if I find… As an oncologist, somebody has very high hypertension, is it my role to control that hypertension?

Illness 136

Illness Patient-Centered Screening IT 136

GeriPal

JANUARY 16, 2025

He died in 2024. Eric 13:00 I also love that too, because even on our inpatient ballot of care consult service, whenever somebody says that they’re unrepresented or they don’t have a surrogate, we never believe that until we usually look up. I’m a little bit of a throwback kind of 70s 80s guy. I think it’s.

Patient-Centered 109

Patient-Centered IT Patients Healthcare 109